Sleep Medications for Patients with Impaired Renal Function
For patients with impaired renal function, zolpidem and eszopiclone are preferred sleep medications as they require no dosage adjustment in renal impairment, while melatonin at low doses (0.5-3 mg) is also appropriate as a non-prescription alternative. 1, 2, 3
First-Line Options
Non-Benzodiazepine Receptor Agonists
Zolpidem (Ambien)
Eszopiclone (Lunesta)
Melatonin Receptor Agonists
Melatonin (OTC supplement)
Ramelteon (Rozerem)
- FDA-approved melatonin receptor agonist
- Recommended dosage: 8 mg at bedtime 4
- Short-acting; primarily for sleep onset insomnia
- No short-term usage restriction
Second-Line Options
Sedating Antidepressants
When first-line agents are ineffective or contraindicated, consider:
Trazodone
- Lower doses (25-50 mg) for sleep
- Minimal anticholinergic activity
- Monitor for orthostatic hypotension
Mirtazapine
- Lower doses (7.5-15 mg) more sedating than higher doses
- May cause weight gain
- Use with caution in renal impairment
Medications to Avoid or Use with Extreme Caution
Benzodiazepines with long half-lives (e.g., flurazepam)
- Risk of accumulation and prolonged sedation
- Increased fall risk, especially in elderly patients
Medications with active metabolites requiring renal clearance
- Morphine, meperidine, and propoxyphene are contraindicated in ESRD due to toxic metabolite accumulation 3
Special Considerations
Dosing Principles
- Start with the lowest effective dose
- Use shorter-acting agents when possible
- Consider timing of administration in relation to dialysis schedule (if applicable)
- Monitor more frequently for adverse effects
Safety Precautions
- Advise patients about potential for disruptive sleep-related behaviors (sleepwalking, sleep-eating, sleep-driving) 4
- Caution against combining with alcohol or other CNS depressants
- Ensure appropriate sleep time is available (7-8 hours)
- Consider fall prevention strategies, especially in elderly patients
Treatment Algorithm
- First attempt: Zolpidem 5-10 mg or Eszopiclone 1-3 mg (lower dose for elderly or frail patients)
- If ineffective or not tolerated: Try melatonin 0.5-3 mg, 2-4 hours before bedtime
- If still ineffective: Consider ramelteon 8 mg at bedtime
- For treatment-resistant cases: Consider low-dose sedating antidepressants (trazodone 25-50 mg)
- Combine with: Cognitive behavioral therapy for insomnia (CBT-I) whenever possible 4
Remember that pharmacological treatment should be supplemented with behavioral and cognitive therapies when possible, as this combination is more effective for long-term management of insomnia 4.